Page last updated: 2024-11-03

ag 1879 and Muscular Dystrophy, Duchenne

ag 1879 has been researched along with Muscular Dystrophy, Duchenne in 1 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sanarica, F1
Mantuano, P1
Conte, E1
Cozzoli, A1
Capogrosso, RF1
Giustino, A1
Cutrignelli, A1
Cappellari, O1
Rolland, JF1
De Bellis, M1
Denora, N1
Camerino, GM1
De Luca, A1

Other Studies

1 other study available for ag 1879 and Muscular Dystrophy, Duchenne

ArticleYear
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies.
    Pharmacological research, 2019, Volume: 145

    Topics: Animals; Cell Line; Cell Survival; Dasatinib; Dystroglycans; Liver; Male; Mice, Inbred mdx; Muscle F

2019